KLK8 protein present in blood (serum) indicates a favorable prognosis for the ovarian cancer patient while elevated protein levels of KLK5, 6, 10 and 11 are markers of a poor clinical outcome.44,46–49. Here, KLK5 is linked to ovarian carcinoma.